By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Secondary ether used as a solvent is isopropyl ether. It is a white liquid that is miscible with organic solvents but only mildly soluble in water. As an extractant and gasoline additive, it oxygenates fuel. It is produced commercially as a byproduct during the hydration of propylene to make isopropanol. The acronym DIPE is sometimes used to denote diisopropyl ether.
isopropyl ether only dissolves 0.88% by weight of water at 20 °C, compared to diethyl ether’s 1% by weight dissolution rate. For example, phenols, ethanol, and acetic acid are polar organic molecules that are removed or extracted from aqueous solutions using the specialist solvent diisopropyl ether. As an antiknock agent, it has also been employed.
isopropyl ether has a broad liquid range, making it suitable for recrystallizations in the lab.isopropyl ether is employed to transform thermally labile bromoboranes into isopropoxy derivatives.
Global isopropyl ether market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
With the introduction of a new on-purpose isopropyl Ether (IPE) facility, Novacap, a global leader in the pharmaceutical and chemical industries and a significant European player in oxygenated solvents, is continuing its development strategy for high added-value goods.
The brand-new, fully integrated plant was created employing a cutting-edge, eco-friendly, and energy-efficient process.
IPE will broaden the selection of oxygenated solvents that the division now produces, which also includes isopropanol, acetone, and more recently, isopropyl acetate, which was awarded the prestigious Pierre Potier medal for scientific and technological innovation in 2014.
In the pharmaceutical sector, IPE is frequently employed as an extractive solvent and in the crystallisation of active medicinal substances.
IPE is also employed in novel environmental applications such waste water treatment as a specialised solvent for resins, coatings, and dyes.
Built on the Roussillon chemical platform, the new factory will have a capacity of about 5,000 tonnes. With a primary development focus on the pharmaceutical industry markets, this initiative is an essential component of the Novacap Group’s strategy to become a leader in chemicals and life sciences.
